Back

dr. R.P. (Richard) Meijer

dr. R.P. (Richard) Meijer

Associate Professor - medical
dr. R.P. (Richard) Meijer
  • Department of Urological Oncology

Research Programs

Strategic Program Cancer

Biography

Biography

Current positions

2018-present    Associate Professor Oncological Urology, UMC Utrecht

2018-present    Head Department Oncological Urology, UMC Utrecht Cancer Center 

2012-present    Oncological Urologist, University Medical Center Utrecht (UMCU), The Netherlands

2016-present    Deputy Chief of the Specialist Medical Training Urology UMC Utrecht

2016-present    Chairman of the Oncological Urology Tumour Group, UMCU Cancer Center

2016-present    Member of the Oncology Committee, UMCU Cancer Center

2016-present    Associate member of ERUS (EAU Robotic Urology Section)

2015-present    Member of the Dutch Uro-Oncological Society (DUOS)

2015-present    Member Workgroup Oncological Urology (WOU) of the Dutch Urological Association                (Dutch: NVU)

2015                 SKMS workgroup Laparoscopy and Robotic Surgery

2014-present    Associate member of ESOU (EAU Section of Oncological Urology)

2011-present    Editorial Board Dutch Journal of Urology (Dutch: Tijdschrift voor Urologie)

Prior positions

2010-2012       Fellowship Oncological Urology, NKI-AVL, Amsterdam, The Netherlands; Supervisor Prof. Dr. S. Horenblas

Oct 2009          Fellowship Laparoscopy, Universitäts Klinikum Leipzig, Germany; Supervisor Prof. Dr. J.U. Stolzenburg

2008-2009       Resident in Urology, University Medical Center Utrecht, The Netherlands; Supervisor Prof. Dr. J.L.H.R. Bosch

2006-2007       Resident in Urology, JBZ, ’s-Hertogenbosch; Supervisor Dr. H.P. Beerlage

2004-2005       Resident in Surgery, Diakonessenhuis Utrecht, Supervisor Dr. G.J. Clevers

 

Current research projects

Research support (institutional)

  • Janssen (Research-grant) (2017-2022)
  • Roche (Research-grant) (2017-2021)
  • Astellas (Research-grant) (2021-2022)
  • Merck (Educational-grant) (2022)
  • Janssen/Astellas/AstraZeneca/MSD/BMS/Roche/Merck (ProBCI support) (2018---)

Company Advisory Boards (institutional):

  • Merck
  • MSD
  • Janssen
  • Bristol-Myers Squibb Company

2023 Framingham selection Urothelial Cancer Issues (Bristol-Myers Squibb Company; institutional)

Side Activities

  1. Afdelingshoofd Oncologische Urologie
  2. Voorzitter UMC Utrecht Expertise Centrum voor testiculaire en extragonadale kiemceltumoren (Zaadbalkanker)
  3. Panellid EAU Richtlijn Spierinvasief en Gemetastaseerd Blaaskanker
  4. ProBCI Stuurgroep (probci.nl)
  5. BlaZIB Stuurgroep (Blaaskankerzorg in Beeld) (IKNL)
  6. Plaatsvervangend opleider Urologie UMCU
  7. Voorzitter tumorwerkgroep Oncologische Urologie UMCU
  8. Lid Oncologie commissie UMCU Cancer Center
  9. Lid Werkgroep Oncologische Urologie (WOU) van de NVU
  10. Associate member ESOU
  11. Associate member ERUS

Research Output (106)

The prevalence and intensity of late effects in patients with testicular germ cell tumors:A first step of instrument development using a stepwise approach

Enzlin Roos, Vervoort Sigrid C.J.M., Suelmann Britt B.M., Meijer Richard P., Teunissen Saskia C.C.M., Zweers Danielle Jun 2023, In: European Journal of Oncology Nursing. 64 , p. 1-8

Minimum Volume Standards:An Incentive To Perform More Radical Cystectomies?

Nuijens Siberyn T., van Hoogstraten Lisa M.C., Meijer Richard P., Kiemeney Lambertus A., Aben Katja K.H., Witjes J. Alfred May 2023, In: European Urology Open Science. 51 , p. 47-54 8 p.

EffectiveNess of a multimodal preHAbilitation program in patieNts with bladder canCEr undergoing radical cystectomy:protocol of the ENHANCE multicentre randomised controlled trial

Akdemir Emine, Sweegers Maike G., Vrieling Alina, Rundqvist Helene, Meijer Richard P., Leliveld-Kors Annemarie M., Van Der Heijden Antoine G., Rutten Vera C., Koldewijn Evert L., Bos Siebe D., Wijburg Carl J., Marcelissen Tom A.T., Bongers Bart C., Retèl Valesca P., Van Harten Wim H., May Anne M., Groen Wim G., Stuiver Martijn M. 7 Mar 2023, In: BMJ Open. 13

Patient preferences for treatment modalities for localised prostate cancer

Teunissen Frederik R, Hehakaya Charisma, Meijer Richard P, van Melick Harm H E, Verkooijen Helena M, van der Voort van Zyp Jochem R N Mar 2023, In: BJUI compass. 4 , p. 214-222 9 p.

Positron Emission Tomography/Computed Tomography for Staging of Bladder Cancer:A Continuing Clinical Controversy

Mertens Laura S, Meijer Richard P, Alfred Witjes J 3 Oct 2022, In: European Urology. 83 , p. 95-96 2 p.

The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC):the first platform facilitating 'trials within cohorts' (TwiCs) for the evaluation of interventions for prostate cancer

Teunissen Frederik R, Willigenburg Thomas, Meijer Richard P, van Melick Harm H E, Verkooijen Helena M, van der Voort van Zyp Jochem R N 21 Jul 2022, In: World Journal of Urology. 40 , p. 2205-2212 8 p.

Impact of the COVID-19 outbreak on prostate cancer care in the Netherlands

Deukeren Désirée van, Heesterman Berdine L, Roelofs Lianne, Kiemeney Lambertus A, Witjes J Alfred, Smilde Tineke J, Leenders Geert J L H van, Incrocci Luca, Vanneste Ben G L, Meijer Richard P, Siesling Sabine, Bezooijen Bart P J van, Aben Katja K H, 2 Apr 2022, In: Cancer treatment and research communications. 31 , p. 1-11

Improving robotic skills by video review

van der Leun Josephine A, Siem Gabriel, Meijer Richard P, Brinkman Willem M 9 Mar 2022, In: Journal of Endourology. 36 , p. 1126-1135 10 p.

Non-metastatic muscle-invasive bladder cancer:the role of age in receiving treatment with curative intent

van Hoogstraten Lisa M C, Witjes J Alfred, Meijer Richard P, Ripping Theodora M, Kiemeney Lambertus A, Aben Katja K H, 8 Feb 2022, In: BJU International. 130 , p. 764-775 12 p.

Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer

Teunissen F. R., Wortel R. C., Wessels F. J., Claes A., van de Pol S. M.G., Rasing M. J.A., Meijer R. P., van Melick H. H.E., de Boer J. C.J., Verkooijen H. M., van der Voort van Zyp J. R.N. Jan 2022, In: Clinical and translational radiation oncology. 32 , p. 29-34 6 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet